tradingkey.logo

OptimizeRx Corp

OPRX
12.480USD
-0.280-2.19%
收盤 12/26, 16:00美東報價延遲15分鐘
232.03M總市值
2888.89本益比TTM

OptimizeRx Corp

12.480
-0.280-2.19%

關於 OptimizeRx Corp 公司

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

OptimizeRx Corp簡介

公司代碼OPRX
公司名稱OptimizeRx Corp
上市日期May 18, 2005
CEOSilvestro (Stephen L)
員工數量106
證券類型Ordinary Share
年結日May 18
公司地址260 Charles Street
城市WALTHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編02453
電話12486516558
網址https://www.optimizerx.com/
公司代碼OPRX
上市日期May 18, 2005
CEOSilvestro (Stephen L)

OptimizeRx Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
139.76K
+3.73%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
76.86K
-2.16%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
74.49K
+19.62%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
69.57K
+3.48%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
46.31K
-2.54%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
43.90K
+29.00%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
30.93K
-26.45%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
14.98K
+193.15%
Mr. Brendan Merrell
Mr. Brendan Merrell
Chief Operating Officer
Chief Operating Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
139.76K
+3.73%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
76.86K
-2.16%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
74.49K
+19.62%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
69.57K
+3.48%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
46.31K
-2.54%

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Whetstone Capital Advisors, LLC
8.09%
Weintraub (Michael)
7.43%
The Vanguard Group, Inc.
5.68%
BlackRock Institutional Trust Company, N.A.
5.67%
Royce Investment Partners
3.63%
其他
69.49%
持股股東
持股股東
佔比
Whetstone Capital Advisors, LLC
8.09%
Weintraub (Michael)
7.43%
The Vanguard Group, Inc.
5.68%
BlackRock Institutional Trust Company, N.A.
5.67%
Royce Investment Partners
3.63%
其他
69.49%
股東類型
持股股東
佔比
Investment Advisor
34.87%
Investment Advisor/Hedge Fund
22.55%
Individual Investor
16.38%
Hedge Fund
12.09%
Research Firm
4.75%
Pension Fund
0.78%
Bank and Trust
0.14%
Insurance Company
0.04%
其他
8.40%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
268
13.52M
72.70%
-5.62M
2025Q2
261
14.95M
80.84%
-7.34M
2025Q1
267
15.34M
83.16%
-6.19M
2024Q4
295
14.49M
78.68%
-4.45M
2024Q3
303
15.96M
87.07%
-2.38M
2024Q2
340
16.48M
89.93%
-3.43M
2024Q1
347
15.94M
87.64%
-3.60M
2023Q4
378
15.63M
86.21%
-4.61M
2023Q3
399
14.49M
86.61%
-5.94M
2023Q2
406
14.23M
85.34%
-7.19M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Whetstone Capital Advisors, LLC
1.51M
8.12%
--
--
Jun 30, 2025
Weintraub (Michael)
1.38M
7.46%
--
--
Apr 29, 2025
The Vanguard Group, Inc.
920.88K
4.96%
-963.00
-0.10%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.09M
5.89%
-72.63K
-6.23%
Jun 30, 2025
Royce Investment Partners
790.64K
4.26%
-203.66K
-20.48%
Jun 30, 2025
Kennedy Capital Management LLC
472.47K
2.54%
-5.93K
-1.24%
Jun 30, 2025
William Blair & Company, L.L.C. (Research)
628.93K
3.39%
-2.10K
-0.33%
Jun 30, 2025
Rice Hall James & Associates, LLC
607.56K
3.27%
+31.39K
+5.45%
Jun 30, 2025
Febbo (William J)
530.85K
2.86%
-83.11K
-13.54%
Apr 29, 2025
Parkman Healthcare Partners LLC
507.42K
2.73%
+32.42K
+6.83%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
AAM Sawgrass US Small Cap Quality Growth ETF
1.37%
Janus Henderson Small Cap Growth Alpha ETF
0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
0.57%
Even Herd Long Short ETF
0.19%
Vanguard US Multifactor ETF
0.1%
Vanguard US Momentum Factor ETF
0.1%
iShares Micro-Cap ETF
0.06%
Principal U.S. Small-Cap ETF
0.05%
Avantis US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.02%
查看更多
AAM Sawgrass US Small Cap Quality Growth ETF
佔比1.37%
Janus Henderson Small Cap Growth Alpha ETF
佔比0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
佔比0.57%
Even Herd Long Short ETF
佔比0.19%
Vanguard US Multifactor ETF
佔比0.1%
Vanguard US Momentum Factor ETF
佔比0.1%
iShares Micro-Cap ETF
佔比0.06%
Principal U.S. Small-Cap ETF
佔比0.05%
Avantis US Small Cap Equity ETF
佔比0.03%
iShares Russell 2000 Growth ETF
佔比0.02%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

OptimizeRx Corp的前五大股東是誰?

OptimizeRx Corp的前五大股東如下:
Whetstone Capital Advisors, LLC
持有股份:1.51M
佔總股份比例:8.12%。
Weintraub (Michael)
持有股份:1.38M
佔總股份比例:7.46%。
The Vanguard Group, Inc.
持有股份:920.88K
佔總股份比例:4.96%。
BlackRock Institutional Trust Company, N.A.
持有股份:1.09M
佔總股份比例:5.89%。
Royce Investment Partners
持有股份:790.64K
佔總股份比例:4.26%。

OptimizeRx Corp的前三大股東類型是什麼?

OptimizeRx Corp 的前三大股東類型分別是:
Whetstone Capital Advisors, LLC
Weintraub (Michael)
The Vanguard Group, Inc.

有多少機構持有OptimizeRx Corp(OPRX)的股份?

截至2025Q3,共有268家機構持有OptimizeRx Corp的股份,合計持有的股份價值約為13.52M,占公司總股份的72.70% 。與2025Q2相比,機構持股有所增加,增幅為-8.14%。

哪個業務部門對OptimizeRx Corp的收入貢獻最大?

在--,--業務部門對OptimizeRx Corp的收入貢獻最大,創收--,占總收入的--% 。
KeyAI